Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense and the kidney

R Oberbauer1, H Murer, G F Schreiner

  • 1Department of Medicine, University of Vienna, Austria.

Kidney & Blood Pressure Research
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal handling of phosphate and sulfate.

Comprehensive Physiology·2014
Same author

Immune cytokines and cardiac disease.

Trends in cardiovascular medicine·2011
Same author

Regulation of phosphate transport in proximal tubules.

Pflugers Archiv : European journal of physiology·2008
Same author

Intestinal phosphate absorption in a model of chronic renal failure.

Kidney international·2007
Same author

Improvement of human islet cryopreservation by a p38 MAPK inhibitor.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
Same author

Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.

Kidney international·2006

Antisense oligonucleotides show promise for gene therapy, effectively limiting tumor growth and arterial neointimal proliferation in vivo. Further research into delivery systems is needed for sustained therapeutic effects, particularly in kidney applications.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Pharmacology

Background:

  • Antisense oligonucleotides (ASOs) are emerging as potent gene-therapeutic agents.
  • Understanding their in vivo kinetics and applications is crucial for therapeutic development.

Purpose of the Study:

  • To review the in vivo kinetics of antisense oligonucleotides.
  • To explore their current and potential research and therapeutic applications.

Main Methods:

  • Review of experimental data on antisense oligonucleotide efficacy.
  • Focus on in vivo studies targeting specific genes and cellular processes.

Main Results:

  • Promising results with ASOs targeting cell proliferation genes (c-myc, c-myb, Kras, cdc-2).

Related Experiment Videos

  • Demonstrated limitation of experimental tumor growth and arterial neointimal proliferation.
  • Transient gene suppression observed in kidney proximal tubule cells after parenteral administration.

    • Conclusions:

    • ASOs show significant potential for treating proliferative diseases.
    • Advanced delivery systems are necessary for enhanced and sustained therapeutic efficacy, especially in complex organs like the kidney.